Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT00413504
First received: December 7, 2006
Last updated: February 2, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given